1997
DOI: 10.1097/00007890-199707270-00001
|View full text |Cite
|
Sign up to set email alerts
|

Insulin-Like Growth Factor-I Ameliorates Delayed Kidney Graft Function and the Acute Nephrotoxic Effects of Cyclosporine1

Abstract: In evaluating this study it should be recognized that the animal models studied, although widely used, differ from the human condition. However, IGF-I and des(1-3)IGF-I exhibit properties that strongly suggest their value in preventing clinical DGF, and they deserve further studies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

1998
1998
2016
2016

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 14 publications
(7 citation statements)
references
References 16 publications
0
7
0
Order By: Relevance
“…It has been demonstrated in several reports that IGF-1 prevents apoptotic cell death in neuronal cells (3,10,26,35), as well as in cardiac fibroblasts (28). In the kidney, IGF-1 was found to accelarate recovery in renal failure (18) and to improve the acute nephrotoxic effects of cyclosporine (24). Since our results show so far that AmB does not cause significant apoptosis in mesangial cells and since mesangial cells are known to be the only cells of the kidney to produce IGF-1 intrinsically (2, 9, 34), we hypothesize that IGF-1 might elicit a protective effect in toxic renal injury.…”
Section: Resultsmentioning
confidence: 98%
“…It has been demonstrated in several reports that IGF-1 prevents apoptotic cell death in neuronal cells (3,10,26,35), as well as in cardiac fibroblasts (28). In the kidney, IGF-1 was found to accelarate recovery in renal failure (18) and to improve the acute nephrotoxic effects of cyclosporine (24). Since our results show so far that AmB does not cause significant apoptosis in mesangial cells and since mesangial cells are known to be the only cells of the kidney to produce IGF-1 intrinsically (2, 9, 34), we hypothesize that IGF-1 might elicit a protective effect in toxic renal injury.…”
Section: Resultsmentioning
confidence: 98%
“…This study clearly showed that trophic factors influenced cold ischemic injury by interaction with the tissue during cold storage and not merely by being present during rewarming and reperfusion. Some of the factors used here, such as IGF‐1 and EGF, have the potential to exert beneficial effects by affecting mechanisms of reperfusion injury (16–18). However, we have shown that these potential effects on reperfusion did not play a role in the improved kidney function obtained with trophic factors when used, as in this study, only in the storage solution.…”
Section: Discussionmentioning
confidence: 99%
“…IGF‐1 is protective against renal injury. It can accelerate recovery from ischemia when administered either at the time of injury, after 24 h or if given prior to injury (18, 63). IGF‐1 likely decreases during storage due to a specific IGF‐1 degrading system in kidney membranes (64), which may render the graft more susceptible to cold ischemic injury.…”
Section: Discussionmentioning
confidence: 99%
“…Recently Chao et al (43) demonstrated that local insulinlike growth factor-I gene transfer, which constitutively activates Akt but does not increase serum insulin-like growth factor-I, thus avoiding increased inflammatory reactions, protects cardiomyocytes from ischemia/reperfusion. Some have demonstrated that insulin-like growth factor-I treatment ameliorates ischemic acute renal failure (44,45), whereas others have reported that insulin-like growth factor-1 worsens kidney I/R injury because of greater inflammatory responses (46,47).…”
Section: Gender Differences On Renal Function and Morphology Aftermentioning
confidence: 99%